Drug Type Biological products |
Synonyms |
Target |
Mechanism HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators), HLA class I antigen A-24 alpha modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | FR | - |